Systematic analysis of palatal transcriptome to identify cleft palate genes within TGFβ3-knockout mice alleles: RNA-Seq analysis of TGFβ3 Mice by Ferhat Ozturk et al.
Systematic analysis of palatal transcriptome to
identify cleft palate genes within TGFβ3-knockout
mice alleles: RNA-Seq analysis of TGFβ3 Mice
Ozturk et al.
Ozturk et al. BMC Genomics 2013, 14:113
http://www.biomedcentral.com/1471-2164/14/113
Ozturk et al. BMC Genomics 2013, 14:113
http://www.biomedcentral.com/1471-2164/14/113RESEARCH ARTICLE Open AccessSystematic analysis of palatal transcriptome to
identify cleft palate genes within TGFβ3-knockout
mice alleles: RNA-Seq analysis of TGFβ3 Mice
Ferhat Ozturk1,4, You Li2, Xiujuan Zhu1, Chittibabu Guda2,3 and Ali Nawshad1*Abstract
Background: In humans, cleft palate (CP) accounts for one of the largest number of birth defects with a complex
genetic and environmental etiology. TGFβ3 has been established as an important regulator of palatal fusion in mice
and it has been shown that TGFβ3-null mice exhibit CP without any other major deformities. However, the genes that
regulate cellular decisions and molecular mechanisms maintained by the TGFβ3 pathway throughout palatogenesis are
predominantly unexplored. Our objective in this study was to analyze global transcriptome changes within the palate
during different gestational ages within TGFβ3 knockout mice to identify TGFβ3-associated genes previously unknown
to be associated with the development of cleft palate. We used deep sequencing technology, RNA-Seq, to analyze the
transcriptome of TGFβ3 knockout mice at crucial stages of palatogenesis, including palatal growth (E14.5), adhesion
(E15.5), and fusion (E16.5).
Results: The overall transcriptome analysis of TGFβ3 wildtype mice (C57BL/6) reveals that almost 6000 genes were
upregulated during the transition from E14.5 to E15.5 and more than 2000 were downregulated from E15.5 to E16.5.
Using bioinformatics tools and databases, we identified the most comprehensive list of CP genes (n = 322) in which
mutations cause CP either in humans or mice, and analyzed their expression patterns. The expression motifs of CP
genes between TGFβ3+/− and TGFβ3−/− were not significantly different from each other, and the expression of the
majority of CP genes remained unchanged from E14.5 to E16.5. Using these patterns, we identified 8 unique genes
within TGFβ3−/− mice (Chrng, Foxc2, H19, Kcnj13, Lhx8, Meox2, Shh, and Six3), which may function as the primary
contributors to the development of cleft palate in TGFβ3−/− mice. When the significantly altered CP genes were
overlaid with TGFβ signaling, all of these genes followed the Smad-dependent pathway.
Conclusions: Our study represents the first analysis of the palatal transcriptome of the mouse, as well as TGFβ3
knockout mice, using deep sequencing methods. In this study, we characterized the critical regulation of palatal
transcripts that may play key regulatory roles through crucial stages of palatal development. We identified potential
causative CP genes in a TGFβ3 knockout model, which may lead to a better understanding of the genetic mechanisms
of palatogenesis and provide novel potential targets for gene therapy approaches to treat cleft palate.
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Cleft palate (CP) is the second most common birth defect
(1/800 live births) in humans, and is caused by the lack of
fusion of the embryonic palatal shelves early in gestation
(6–10 weeks) [1]. The formation of a continuous palate
is a complex process involving multiple steps, including:
palatal shelf growth, elevation, attachment, and fusion.
The stages of palatogenesis are regulated by numerous
genes that are essential for normal palate development.
Our laboratory has a long-standing interest in identify-
ing the genetic and molecular mechanisms that regulate
palatogenesis in order to understand the factors
involved in the development of orofacial clefts [2-11]. It
has been shown that both genetic and environmental
elements contribute to the development of cleft palate
[12,13]. We previously presented that Transforming
Growth Factor (TGF)-β isoforms play essential roles in
the regulation of palatal morphogenesis, including the
finding that TGFβ3 mediates palatal fusion both in pri-
mary cells and organ culture [5,14,15]. According to se-
veral population-based mutation screening studies, TGFβ3
is considered a candidate gene for non-syndromic CP in
humans [16-22]. Furthermore, TGFβ3 knockout mice are
born with CP but lack other major defects [23-25].
In our earlier studies [26], we examined gene expression
during palatal fusion in normal mice using microarray
analysis and detected several genes essential for comple-
tion of palatal development. As genome sequencing tech-
nologies advanced, it has become feasible to systematically
analyze global transcriptomal changes and identify the key
molecular components in the developing palate during
crucial stages of palatogenesis. Failure to regulate func-
tional or structural genes during these stages may result in
cleft palate. Next-generation sequencing (NGS) technolo-
gies, or RNA-Seq, have recently emerged as a revolution-
ary tool of transcriptomics [27] by revealing the complex
landscape of the transcriptome with high-throughput at
an incomparable level of sensitivity and accuracy [27,28].
The results of RNA-Seq demonstrate high levels of repro-
ducibility for both technical and biological replicates
[29,30]. The analysis of TGFβ3 knockout mice by RNA-Seq
provides a valuable resource to facilitate our understanding
of the complex genetic and molecular mechanisms of
palatogenesis. This technology also allows us to detect al-
lelic and splice variants of some of the genes involved in
palate development in TGFβ3 knockout mice, which is cur-
rently beyond the scope of this article.
Evidence suggests that TGFβ3 is essential to palato-
genesis, especially during embryonic days (E) E14.5 to
E16.5. However, the cellular mechanisms maintained
and regulated by TGFβ3 signaling have not been exten-
sively explored to enable an understanding of those
genes functionally regulated by TGFβ3 during normal
palatogenesis or those genes deregulated in TGFβ3-nullmice. Our objective in this study was to analyze tran-
scriptome changes and their contribution to the deve-
lopment of CP among different gestational ages and
TGFβ3 knockout alleles. In this study, we analyzed the
transcriptome of TGFβ3 mice by RNA-Seq at crucial
stages of palatogenesis, including: palatal convergence,
adhesion, and fusion; and we characterized some crucial
transcripts that may play key regulatory roles throughout
palatal development. We used palatal shelves extracted
from E14.5, E15.5 and E16.5 allelic mice to analyze dif-
ferential expression patterns of their transcriptome
throughout the palatal developmental process. The over-
all transcriptome analysis of TGFβ3 WT mice revealed
that almost 6000 genes were upregulated during the
transition from E14.5 to E15.5 and more than 2000 were
downregulated from E15.5 to E16.5, which suggests that
regulation of these transcripts is essential during the
stages of palate development. In order to streamline the
analysis of the high number of transcripts, we downsized
the list of genes to CP genes only. Using biological
databases, we categorized a comprehensive inventory of
CP genes both in human and mouse genomes and fo-
cused on their differential expressions and biological
interpretations. Unexpectedly, the expression patterns of
CP genes between TGFβ3+/− and TGFβ3−/− were not
significantly different from each other, and the expres-
sion of the majority of CP genes remained unchanged
from E14.5 to E16.5. Using this data, we identified 8
unique genes (Chrng, Foxc2, H19, Kcnj13, Lhx8, Meox2,
Shh, and Six3), which may regulate cleft palate formation
in TGFβ3−/− mice. We used Ingenuity Pathway Analysis
(IPA) software to analyze downstream effects of these
genes on biological functions, molecular networks, and
regulatory pathways- particularly TGFβ signaling. This is
the first genome scale analysis of the palatal transcrip-
tome of mice generated by RNA-Seq technology during
critical stages of palatogenesis. This data will allow the
comprehensive analysis of TGFβ signaling during
palatogenesis and provide information on the chronological
regulation of downstream TGFβ-activated transcription
factors that function to induce cellular differentiation,
transformation, and apoptosis.
Results
Analysis of RNA-seq data
As outlined in the experimental workflow of our study
(Figure 1), RNA samples were extracted from mouse pal-
atal tissues of TGFβ3 knockout mice (homozygous (−/−),
heterozygous (+/−), and wildtype (+/+)) at three develop-
mental stages (E14.5, E15.5, and E16.5); libraries were
prepared, converted to cDNA, and sequenced by using
the Illumina HiSeq2000 next generation sequencer. The
bioinformatics analysis of RNA-Seq data was processed
using the Tuxedo protocol [31], which includes TopHat,
Figure 1 Experimental workflow of the study. RNA samples were extracted from mouse palatal tissues of TGFβ3 knockout mice (homozygous,
heterozygous, and wildtype) at three developmental stages (E14.5, E15.5, and E16.5); libraries were prepared, converted to cDNA, and sequenced
by using the Illumina HiSeq2000 next generation sequencer. Fastq files were uploaded to the server for quality control analysis of sequence reads
using FastQC. There were no sequence manipulation processes performed for any fastq file, given that the quality score was high at both the
30 and 50 ends. All of the reads were mapped to the reference genome (mm9, built name NCBIM37) by using TopHat. Quantification of
transcripts, statistics tests for differential expression, and detection of splice variants were performed using Cufflinks; quality assessments of
biological and technical replicates were performed using CummeRbund; and pairwise comparisons of samples and differential expression of
transcripts were analyzed using CuffDiff. Venn diagrams of all significantly altered (FC≥ 2.0) transcripts were drawn using the R VennDiagram
package [75]. CP related genes (n = 322) were extracted from human (OMIM) and mouse (MGI) genome databases. CP genes were classified
based on their patterns of expression (n = 9) for each genotype and their heatmaps were generated using the R pheatmap package. Expression
pattern groups of CP genes were uploaded to IPA software as datasets and core analyses were run to detect downstream effects: canonical
pathways and biological functions relevant to sample datasets.
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genes were identified from OMIM and MGI databases
and downstream effects were analyzed using IPA.
Our data clearly demonstrate that TGFβ3 wildtype
(+/+) palates from E15.5 expressed increased TGFβ3 pro-
tein, double the expression of heterozygous (+/−) and as
expected the homozygous (−/−) palates were completely
devoid of any TGFβ3 expression (Additional file 1).
Extracted RNA samples were evaluated by RNA integrity
numbers (RIN) to monitor quality and degradation with
BioAnalyzer (Agilent Technologies, Palo Alto, CA). We
confirmed that all of the palatal RNA samples had an
RIN ≥ 8.4, indicating the high quality and low degradation
of our experimental samples (Additional file 2). The RNA
libraries were prepared for cDNA conversion and the
samples were sequenced by Illumina techniques using HiSeq
2000. We obtained total reads from the RNA-Seq samples
ranging from 14 million to 96 million (Additional file 3).
Among all samples, only 4 samples have less than 40 mil-
lion reads. We did not apply sequence manipulations on
either 30 or 50 ends because the RNA-Seq sequencing qua-
lity was high across all samples based on our FastQC data
quality control analysis. The relative abundance of
transcripts was normalized to the total read number and
shown as fragments per kilobase per million (FPKM) and
mapped via Cufflinks.
In order to evaluate the reproducibility of our experi-
mental samples and procedures, two independent bio-
logical and technical replicates for each gestational ageFigure 2 Validation of biological and technical replicates using Cumm
and (B) technical replicates were compared. Since the read number per tra
was transformed by log10. Each dot represents data from one transcript. Th
(r = 0.98, Pearson’s correlation; p < 0.001 two tail). Additional scatter plots foand each allele resulting in 36 (n = 9 × 2 × 2) paired-end
samples were assayed [32]. Using the scatter plots
generated by CummeRbund, biological and technical
replicates of our samples were validated based on the
comparison of their read numbers per transcript. We
detected a high correlation among both the biological
and technical replicates of each gestational age and allele
(Figure 2) (r = 0.98, Pearson’s correlation; p < 0.001). The
replicates of E14.5 of TGFβ3−/− mice are presented in
Figure 2. Additional scatter plots for all of the other
samples with their replicates are shown in Additional file
4. Because the expression values (FPKM) of certain CP
related genes differed significantly among the gestational
ages, we transformed the FPKM value of each gene into
log10 (FPKM + 1), rounded up to 2 decimal places, and
used transformed values for further analysis.
Overall transcriptome expression profile
Using the R VennDiagram package, we created Venn
diagrams to illustrate the number of transcripts in each
experimental group that passed the significance and fold
change (FC ≥ 2.0) thresholds designated by Cufflinks
(Additional file 5). From our overall transcriptome ana-
lyses of TGFβ3 knockout mice alleles (Table 1), in all
genotypic groups, the majority of the differentially
expressed transcripts between E14.5 and E15.5 were
upregulated: 62% for TGFΒ3−/− (n = 1721), 53% for
TGFΒ3+/− (n = 1063), and 80% for WT (n = 5946). Out of
1721 transcripts upregulated in TGFΒ3−/−, 1030 (60%)eRbund. The read numbers per transcript between the (A) biological
nscript (FPKM value) ranged from 0 to >10,000, the read number + 1
ere was a high correlation between the two sequencing results
r the other samples are shown in the Additional file 4.
Table 1 Number of transcript changes among TGFβ3
alleles
All Significant E14.5 - E15.5 E14.5 - E16.5 E15.5 - E16.5
TGFβ3−/− 1806 2096 747
TGFβ3+/− 1170 1262 783
WT 5966 1903 2256
Upregulated
TGFβ3−/− 1721 1941 629
TGFβ3+/− 1063 1181 574
WT 5945 1835 417
Downregulated
TGFβ3−/− 86 155 118
TGFβ3+/− 108 81 209
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of the upregulated genes in WT (30%, n = 1792) were
downregulated between E15.5 and E16.5, but not in
TGFΒ3−/−’s E15.5 to E16.5 (Table 1). The names of the
genes significantly increased from E14.5 to E15.5 followed
by downregulation in E16.5 and their corresponding
Venn Diagrams are presented in Additional file 6. This
first-up-then-down pattern of expression suggests that these
transcripts may be crucial at E15.5, which corresponds to
the stage of midline epithelial seam (MES) degradation and
palatal fusion. Since it was not feasible to analyze all signifi-
cantly altered genes during palatal stages, we have shortlisted
the genes to be analyzed to CP-causing genes only.
Identification of CP related genes and their expression
patterns
Following the identification of genes causing CP in humans
and mice, as described in the methods, we generated a
Venn diagram to detect common genes between humans
and mice that cause CP after becoming dysfunctional
(Additional file 7). We identified 37 common genes that
cause CP in both species. Within the human CP list, there
were 194 transcripts that share orthologous copies with
mice. We approached these genes as putative CP genes,
considering that their KO models have not been generated
yet. Overall, the CP gene list we developed includes 322
genes: 128 genes derived from mouse and 230 genes
derived from human databases (Table 2). For an enhanced
visualization of the expression values (FPKM) of all CP
genes (n = 322), a Circos image was drawn based on the cir-
cular composition of CP genes located on human
chromosomes [33] (Additional file 8).
On the basis of our differential expression profile data be-
tween genotypes and gestational ages (Table 1), we decided togroup and analyze the potential CP genes based on their ex-
pression patterns throughout different stages of palatogenesis.
We categorized the 322 CP genes identified above into 9 pos-
sible expression patterns based on the comparison of their ex-
pression values (upregulated, downregulated, or unchanged)
across the 3 different gestational age groups analyzed by
RNA-seq (E14.5, E15.5, and E16.5) (Figure 3). The patterns
(p) represent the change in expression value of the transcript
first from E14.5 to E15.5, and second from E15.5 to E16.5,
which is explained in detail in Figure 3. The genes in each ex-
pression pattern group are listed and common genes among
them are diagrammed in Additional file 9.
Considering the differential expression of CP genes
throughout palatogenesis, we generated individual heat-
maps according to the expression patterns of CP related
genes and grouped them into corresponding genotypes
(Figure 4). In TGFΒ3−/−, the majority of transcripts
(n = 294; 92%) were placed in p1, which denotes unchanged
expression of genes throughout gestation. Similarly, in
TGFΒ3+/− samples, the majority of transcripts were in p1
(n = 293; 91%). Surprisingly, the list of genes in p1 from
TGFΒ3−/− and TGFΒ3+/− were highly comparable (92%)
(Additional file 9). The genes clustered in p1 unique to
TGFΒ3−/−, but not in TGFΒ3+/−, were Chrng, Foxc2, H19,
Kcnj13, Lhx8, Meox2, Shh, and Six3 (Table 3). We
concluded that these 8 genes demand additional attention
due to their unchanged level of expression during crucial
stages of palatogenesis.
Finally, in WT samples, the transcripts were more
equally dispersed into p1, p2 and p4 as 29%, 32%, and
23% respectively. These results suggest that in normal
mice, the majority of CP transcripts are required to be
upregulated between E14.5 and E15.5 (denoted as p2
and p4), which corresponds to the most crucial stages of
palatogenesis- the adhesion and the fusion stages [34].
Some of these upregulated genes were eventually
downregulated (p4) or remained at the same expression
levels (p2), which suggest that they may contribute to
the final phase of palate development.
Downstream pathway analysis of CP genes
We used the IPA software to determine how the expres-
sion pattern-clustered CP genes interconnected with each
other to facilitate cellular biofunctions and signaling.
According to the core analysis of all CP genes (n = 322)
using the IPA, the most significant top 5 cellular functions
were cellular development, gene expression, cellular growth
and proliferation, cell signaling and cell morphology
(Table 4). Although the numbers of molecules were higher
in some cellular functions, the ranking was based on
p-values calculated by IPA according to relevance of datasets
with IKB. Differentially expressed molecules clustered into
GO of these cellular biofunctions are tabulated in Additional
file 10. The pattern-oriented distribution of the top cellular
Table 2 List of genes causing CP according to MGI and OMIM databases (n = 322)
Acvr1 Lhx8 Cask ATR FLNB MEGF10 RPL11
Akap8 Luzp1 Cdkn1c ATRX FLVCR2 MID1 RPL5
Ap2b1 Meox2 Chd7 B3GALTL FRAS1 MKS1 RPS17
Apaf1 Mmp14 Col2a1 B3GAT3 FREM2 MLL2 RPS19
Bmp7 Mmp16 Dhcr7 B9D1 FTO MSX2 RPS7
Bnc2 Mn1 Dlx5 BCOR G6PC3 MTHFR SALL4
Boc Mnt Efnb1 BMP2 GABRB3 MUTYH SC5DL
Cacna1s Msc Eya1 BMP4 GATA6 MYH3 SCARF2
Cdon Ncoa6 Fgf10 BMPER GCMB NBS1 SEMA3E
Chrd Ncor2 Fgfr1 BRAF GDF1 NEB SF3B4
Chuk Osr2 Fgfr2 BRIP1 GDF6 NEK1 SHFM3
Crebbp Pax9 Flna BUB1B GJA1 NIPBL SLC26A2
Crk Pbx1 Foxc2 CANT1 GJB2 NKX2-5 SLC35D1
Ctgf Pcgf2 Foxe1 CASR GLI3 NKX2-6 SMOC1
Ctnnb1 Pdgfc Gad1 CDC6 GPC3 NSD1 SMS
Dlg1 Pdgfra Hoxa2 CDH1 GUSB OFC4 SOX2
Dlx1 Pds5a Impad1 CFC1 H19 OFD1 SPECC1L
Dlx2 Pds5b Inpp5e CHRNA1 HCA1 ORC1 SPINT2
Ednrb Phc1 Irf6 CHRND HPGD OTX2 SPTLC1
Ext1 Phc2 Kcnj2 CHRNG HVEC PAX3 SRY
Fgf18 Pkdcc Msx1 CHST14 HYAL1 PAX8 STRA6
Fgf9 Prdm16 Pitx1 CHSY1 HYLS1 PEX7 TAB2
Fign Prrx2 Prrx1 COL11A1 ICK PHF8 TBX15
Foxf2 Ptprf Ror2 COL11A2 IL1B PIGL TBX19
Foxg1 Ptprs Runx2 COL9A2 IL1RN PIGV TBX4
Fst Rad23b Satb2 COLEC11 IMAGE PIK3CA TBX5
Fuz Rfng Shh COMT IRF1 PLCB4 TCTN2
Fzd1 Rspo2 Six3 CRLF1 KAL1 POLR1C TGFβ1
Fzd2 Ryk Sox9 DGCR2 KAT6B POLR1D TGFβR1
Gab1 Ryr1 Sumo1 DHCR24 KCNJ13 POMT1 TMCO1
Gli2 Sfn Tbx1 DHODH KIAA1289 POMT2 TMEM216
Gpr124 Shox2 Tbx22 DIS3L2 KIF22 PORCN TMEM67
Grb2 Sim2 Tcof1 DOK7 KIF7 PQBP1 TRIM37
Gsk3b Skor2 Tfap2a DXS423E KLF6 PROKR2 TRPS2
Hand2 Slc32a1 TGFβ3 DYNC2H1 KRAS PTCH1 TWIST1
Hoxa1 Snai1 TGFβr2 EFTUD2 L1CAM PTEN UBB
Hs2st1 Snai2 Tp63 EPHB2 LMNA PTH VCAN
Ift172 Sox11 ABCD3 ERBB2 LMX1B PTPN11 WDR65
Ift88 Sox5 ACAN ERCC5 LRP4 PXMP3 WNT3
Inhba Tbx10 ACTB ESCO2 MADH3 RAI1 WNT5A
Inhbb Tbx2 ALX1 FAM123B MAP2K1 RAPSN WNT7A
Itgav Tbx3 ALX3 FAM20C MAP2K2 RB1 WT1
Itgb8 TGFβ2 ARHGAP31 FBN1 MASP1 RBM10 ZEB2
Jag2 Tshz1 ARID1B FGD1 MBTPS2 RECQL4 ZIC2
Jmjd6 Wdr19 ARNT FGF8 MCOPS8 RIPK4 ZIC3
Kif3a Zeb1 ASXL1 FGFR3 MED12 RPGRIP1L ZMPSTE24
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Figure 3 Expression patterns of CP genes through palatal
stages: FPKM values of each CP gene were transformed into
log10 (FPKM + 1) and rounded up to 2 decimal places. These 322
CP genes were categorized into 9 possible expression patterns (p)
based on the comparison of the transformed FPKM values with
FC≥ 2.0 across 3 different gestational groups for each genotype
(n = 3). The patterns represent the expression value of the transcript
first from E14.5 to E15.5, then from E15.5 to E16.5. Each pattern is
color-coded to differentiate patterns for further analysis.
p1 unchanged-unchanged (remain unchanged); p2 upregulated-
unchanged; p3 unchanged-upregulated; p4 upregulated-
downregulated; p5 upregulated-upregulated; p6 downregulated-
unchanged; p7 downregulated-upregulated; p8 unchanged-
downregulated; and p9 downregulated-downregulated.
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illustrated with a color coded matrix with the darker color
representing higher relevance between cellular functions
and uploaded CP gene pattern datasets (Figure 5).
The CP genes unique to p1 of TGFΒ3−/− (n = 8) may
have necessary functions for the complete development of
palatal shelves. Therefore, we analyzed the interaction of
these genes with each other, as well as with key
biofunctions and TGFβ signaling using IPA (Figure 6). We
found that 5 of these genes (Shh, Foxc2, Six3, Meox2, and
H19) are closely related to each other, with Tnf (tumor ne-
crosis factor) and Ccnd1 (Cyclin d1) being their intersecting
molecules. These genes were mostly associated with cell
morphology and cell death biofunctions, and were indi-
rectly associated with TGFβ signaling through Pias4 (pro-
tein inhibitor of activated STAT, 4).
According to IPA core analysis, there were 19 molecules
associated with TGFβ signaling [Ratio: 19/89 (21%)] among
all of the CP genes (n = 322). TGFβ signaling molecules along
the pathway and their cellular locations are illustrated in
Figure 7. TGFβ signaling transcripts expressed in bothTGFΒ3
−/− and TGFΒ3+/− were (n = 18): Acvr1, Bmp2, Bmp4,
Bmp7, Crebbp, Grb2, Inhba, Inhbb, Kras, Map2k1, Map2k2,
Nkx2-5, Runx2, Smad3, TGFβ2, TGFβ3, TGFβr1, TGFβr2
(Table 3). All of these molecules followed the p1 expression
pattern, which represents a uniform level of expression
throughout all time points. However, within WT transcripts,
TGFβ-associated molecules were almost equally distributed
among p1, p2, p4, and p8. All represented TGFβ pathway
molecules (n = 19) were grouped into genotypes according to
their expression patterns (Table 5). When the significantly
altered CP genes were overlaid with TGFβ signaling, all of
these genes followed the Smad-dependent pathway (Figure 7).Discussion
Global transcriptome of TGFβ3 alleles
Palatogenesis is a complex process involving multiple
steps, including: palatal shelf growth, elevation, adhesion
and fusion (Additional file 11). It requires the orchestra-
tion of several key cellular functions (such as cellular
Figure 4 (See legend on next page.)
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(See figure on previous page.)
Figure 4 CP genes represented in pattern-oriented heatmaps. Transcripts were clustered based on expression patterns (n = 9) and heatmaps
were constructed using the R pheatmap package. Each column corresponds to the transformed FPKM value of transcripts in duplicate, and each
row corresponds to a gene. None of the genotypes had transcripts clustered in p9. Additionally, p4 in TGFΒ3−/− and p5 in TGFΒ3+/− did not
contain transcripts. Therefore, the total number of CP gene patterns/genotype groups is 22. The increasing intensity of red to yellow signifies a
higher level of expression (FPKM) in the given sample of a specific transcript. The list of genes for each particular pattern and genotype are
shown in Additional file 9.
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and death) regulated by numerous genes and signaling
pathways. It has been well documented that disruption
of structural and regulatory genes involved in any stage
of palatogenesis, which occurs between E11.5 and E16.5
in mice, contributes to the formation of cleft palate [34].
On the basis of our studies and others [5,6,35], the
stages from E14.5 to E16.5 have been identified as the
most critical phases. During these stages, the palatal
shelves adhere to each other with a seam and the seam
begins to disintegrate in order to complete fusion,
resulting in a confluent palate. Therefore, we anticipated
that the majority of the genes contributing to physio-
logical palatogenesis would be progressively regulated
during these phases. In this study, we took advantage of
high-throughput sequencing technology, RNA-Seq, to
quantitatively analyze the expression of transcripts in
mouse embryonic palatal tissues at three developmental
stages.
The integrity and quality of the isolated RNA are the
primary factors contributing to successful RNA-Seq
studies [36], therefore we ensured that our palatal RNA
samples were of high quality based on their RIN (>8.4).
In our study, we used the “paired end” approach for RNA-
Seq, wherein a single 100bp-long read is sequenced at
both ends, which allows the tracking of alternate splice
junctions, as well as further analysis of SNPs, insertions
and deletions; thus providing more accurate and inform-
ative sequencing results from our samples [37,38]. We
submitted the raw reads of RNA-Seq data (fastq files) to
SRA and the assembly data to the Transcriptome Shotgun






Chrng p1 p3 p4 Cholinergic receptor, nicotinic, gamma
Foxc2 p1 p8 p6 Forkhead box C2
H19 p1 p7 p2 Imprinted maternally expressed transc
Kcnj13 p1 p2 p2 Potassium inwardly-rectifying channel,
member 13
Lhx8 p1 p6 p4 LIM homeobox 8
Meox2 p1 p6 p8 Mesenchyme homeobox 2
Shh p1 p3 p4 Sonic hedgehog
Six3 p1 p2 p3 SIX homeobox 3Our global transcriptome analyses of TGFβ3 alleles
showed that significant numbers of transcripts (~6000
genes) were differentially expressed between E14.5 and
E15.5, particularly within the WT fetuses, indicating func-
tional roles of these genes during this time period of
palatogenesis (Table 1). Interestingly, we found lower
numbers of transcriptome alterations between the same
time points within the TGFβ3−/− mice (n = 2770), which
can be explained by the consequential suppression of gene
clusters due to inactivation of the TGFβ3 gene. However it
was surprising to observe that the lowest number of tran-
scriptome changes were in TGFβ3+/− mice, n = 1993,
which are phenotypically identical to WT mice [25]. This
may suggest that only this number of gene alterations is
sufficient to enhance the palatal growth and fusion.
Furthermore, in normal mice (WT) the majority of
transcripts were upregulated during the early transition of
palatogenesis (E14.5 - E15.5) and downregulated during
the later transitions (E15.5 - E16.5), suggesting that these
are critical stages of palatogenesis requiring extensive gene
regulation. This pattern of upregulated-downregulated ex-
pression suggests that particular CP genes may follow the
same expression pattern to stimulate disintegration of the
palatal seam, resulting in a confluent palate.
Understanding the expression of CP genes
The OMIM and MGI databases provide up-to-date and
adequately classified information about genetic diseases
in humans and mice, respectively; therefore, the identifi-
cation of CP related genes from either species was un-
complicated. However the merger of the information
from these databases required further computer analysisType
(muscle) Transmembrane glycoprotein
Transcription factor
ript H19 Non-protein coding RNA




Morphogen – Secreted protein
Transcription factor
Table 4 Differentially expressed molecules clustered into
GO of cellular biofunctions
Category p-Value # Mols
Gene Expression 1.23E-30 151
Cellular Growth and Proliferation 1.48E-23 199
Cell Cycle 2.58E-14 76
Cellular Movement 2.74E-12 107
Cell Signaling 3.20E-22 25
Cell Death 3.44E-12 168
Cell Morphology 4.03E-16 103
TGFβ Signaling 5.02E-18 24
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http://www.biomedcentral.com/1471-2164/14/113to identify common and individual CP genes between the
two species (Additional file 7). To our knowledge, our list
of CP genes (Table 2) covers the most comprehensive
number of genes (n = 322), which cause CP when mutated
in either species alone or both species [39,40].
It was expected that TGFβ3 allelic mice follow 9 dif-
ferent expression pattern combinations during the
E14.5-E15.5 and the E15.5-E16.5 transitions (Figure 3).
Interestingly, none of the genes followed pattern 9,
which represents the continuous downregulation of the
transcript throughout all palatal stages. We observed
that the majority of the CP genes were equally clusteredFigure 5 Downstream effects analysis of CP gene patterns using IPA.
examined in the context of differentially expressed human and mouse gen
pattern/genotype group (n = 22) were uploaded to IPA as individual datase
the Ingenuity Knowledge Base (IKB). Interactions were then queried betwe
generate a set of overlapping direct interaction networks. The significant g
database, and ranked according to their p-values. The cellular processes th
cellular development, cellular growth and proliferation, cell signaling, cell m
The pattern-oriented distribution of the top cellular biofunctions were rank
greater relevance between cellular function and CP gene datasets.into p2, p4, and p8 in WT samples (WT), representing
normal palate development (Figure 4). Conversely, in
both the TGFΒ3−/− and TGFΒ3+/− samples, almost all
CP transcripts (91%) were accumulated in p1, and
demonstrated high similarity between datasets (92%)
(Additional file 9). This suggests that expression regula-
tion of CP genes in both of these allelic mice was either
delayed or abandoned.Unique TGFΒ3−/− genes following the p1 pattern
Although the pattern of transcriptional expression between
TGFΒ3−/− and TGFΒ3+/− are unexpectedly similar,
phenotypic expression of CP occurs only in TGFΒ3−/− and
not in TGFΒ3+/− pups [24,25]. This suggests that the
unique p1 genes of TGFΒ3−/− (n = 8; Chrng, Foxc2, H19,
Kcnj13, Lhx8, Meox2, Shh, and Six3) may play crucial roles
in the completion of palatogenesis. Therefore, we analyzed
their specific functions within the cell, their roles in
palatogenesis, and their interactions with the TGFβ signal-
ing pathway using IPA and GeneCards [41].
Chrng (Cholinergic receptor, nicotinic, gamma) is a trans-
membrane glycoprotein and has been shown to play a role
in neuromuscular organogenesis and ligand binding [42].
Mutation of Chrng causes the developmental disorderThe effects of TGFβ3 alleles on CP genes during palatogenesis were
es using Ingenuity Pathway Analysis (IPA). Entrez IDs of each CP gene
ts. Each identifier was mapped to its corresponding gene object in
en these datasets and all other gene objects stored within IPA to
enes were categorized, compared to functional categories in the IPA
at are most significantly altered in our datasets were: gene expression,
orphology, cell death and survival, cellular movement, and cell cycle.
ed and illustrated in a color coded matrix: the darker color represents
Figure 6 Cellular biofunction and pathway analysis of CP genes unique to p1 of TGFΒ3−/− (n = 8). Entrez IDs of CP genes unique to p1 of
TGFΒ3−/− were identified using the Venn diagram and uploaded to IPA as an individual dataset. Core analysis was run by default settings on IPA,
and the top cellular biofunctions, diseases, and canonical pathways were detected. IPA Path Designer was used to generate the network of these
genes through an overlay of the biofunctions and pathways. Genes belonging to the Unique TGFΒ3−/− p1 list were merged into a network
(Foxc2, H19, Meox2, Six3, Shh) and gray-shaded. Relationships are shown with colored arrows for easy gene identification.
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http://www.biomedcentral.com/1471-2164/14/113multiple pterygium syndrome in humans, exhibited by
isolated CP, short stature, vertebral (spine) defects, joint
contractures, and webbing of the neck, armpit, elbow, and
knee [42,43]. Pterygium is also associated with Irf6 and p63
mutations in humans [44], and both Irf6 and p63 are known
to be closely associated with TGFβ signaling. Nevertheless,
according to current literature, we could not find any
relationships between Chrng and other molecules of the
TGFΒ3−/− unique p1 list (Figure 6), or the TGFβ pathway.
Foxc2 (Forkhead box C2) is a member of the forkhead
box (FOX) family of transcription factors and has been
shown to be functional during development of mesen-
chymal tissues [45]. Mutations in Foxc2 are responsible
for the hereditary lymphedema-distichiasis syndromewith CP observed in some patients [46]. In addition,
Foxc2 is also involved in cancer metastases. In particular,
expression of Foxc2 is induced when epithelial cells
undergo epithelial-mesenchymal transition (EMT) [47].
Recently, Lindley at al. (2010) showed that Foxc2 may
play a role in EMT maintenance when human mammary
epithelial cells are treated with TGFβ [45]. (The Foxc2
knockout mouse is not available, according to KOMP).
Overall, these relationships suggest that Foxc2 could be
a vital element of palatal confluency through facilitation
of EMT. Furthermore, failure of proper Foxc2 transcript
regulation may result in CP in TGFβ3−/− fetus.
H19 is an imprinted maternally expressed transcript and
expresses a long noncoding RNA. It has been shown that
Figure 7 Characterization of CP genes in relation to the canonical TGFβ signaling pathway. The cellular localization of CP genes which
function in the canonical TGFβ pathway was illustrated using IPA Path Designer. CP gene datasets uploaded to IPA were analyzed using default
settings for the core analysis. A total of 19 CP transcripts from these datasets were associated with the TGFβ canonical pathway: ACVR1, BMP2,
BMP4, BMP7, CREBBP, GRB2, INHBA, INHBB, KRAS, MAP2K1, MAP2K2, NKX2-5, RUNX2, SMAD3, TGFβ2, TGFβ3, TGFβR1, and TGFβR2. These datasets
(n = 7) were selected and overlaid with each other using the IPA Path Designer. Color codes reflect the genotype and expression pattern of CP
genes as follows: Orange lines: both TGFβ3−/−p1 and TGFΒβ3+/−p1; green filled: WTp1; light blue filled: WTp2; orange filled: WTp4; and purple
filled: WTp8. The types of molecules are annotated in the legend.
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and Insulin-like growth factor 2 (Igf2), thus the Igf2 and
the H19 genes are proposed to utilize a set of common
enhancers [48,49]. When Thomas et al. (1997) produced
transgenic mice that express the Igf2 gene under the con-
trol of the H19 enhancers, a large fraction of homozygous
mice developed CP [44]. In our network analysis (Figure 6),
we found that H19 is indirectly related with TGFβ signal-
ing through TNF, which suggests that it may play a crucial
role during palatogenesis under regulation of TGFβ.
The Kcnj13 gene encodes a member of the inwardly rec-
tifying potassium channel family of proteins and regulates
ion transmembrane transport and mutations in Kcnj1 are
associated with snowflake vitreoretinal degeneration [50].
There were no significant relationships found between
Kcnj12 and other molecules of the TGFΒ3−/− unique p1
list (Figure 6), or the TGFβ pathway. However, this does
not rule out its potential regulatory interaction with TGFβ
signaling, and therefore demands additional studies to de-
termine its role during palate development.Lhx8 is a member of the LIM homeobox family of tran-
scription factor proteins, which are involved in patterning
and differentiation of various tissue types. Lhx8 is expressed
in the mesenchyme of the mouse palatal structures
throughout their development [11]. Zhao et al. (1999)
showed that in Lhx8 homozygous mutant embryos, the bi-
lateral primordial palatal shelves formed and elevated nor-
mally, but they often failed to make contact and to fuse
properly, resulting in a cleft secondary palate [51]. Inoue M
et al. (2006) proposed that the L3/Lhx8 gene contributes to
epithelial mesenchymal interactions during facial morpho-
genesis and that Fgf-8b and Tgfβ3 were responsible for
Lhx8 expression in the maxillary process [52]. Our RNA-
Seq study of TGFβ3 −/− fetuses further confirmed the re-
quirement of upregulated expression of Lhx8 throughout
palatal morphogenesis.
The Meox2 gene (mesenchyme homeobox 2) encodes
a member of a subfamily of non-clustered, diverged,
antennapedia-like homeobox-containing genes [53,54].
Jin et al. (2006) found that Meox2 is highly expressed in
Table 5 TGFβ pathway molecules grouped into
genotypes with patterns
TGFΒ3−/− TGFΒ3+/− WT
p1 p2 p1 p1 p2 p4 p8
Acvr1 Tgfβ1 Acvr1 Bmp2 Acvr1 Inhba Bmp4
Bmp2 Bmp2 Map2k2 Bmp7 Kras Crebbp
Bmp4 Bmp4 TGFβr1 Grb2 Map2k1 Smad3
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duction of Meox2 gene levels increased the susceptibility
of mice to cleft palate through a novel post-fusion mech-
anism [53]. The posterior cleft in E15.5 Meox2 −/− mice
contained no epithelial cells, therefore they proposed that
Meox2 may function to strengthen the fusing zone of pal-
atal shelves. The lack of strong fusion of epithelial cells
during stable expression of Meox2 may explain why the
palatal shelves of TGFβ3−/− mice attach to each other,
but fail to fuse [25]. Recently, Valcourt et al. (2007) showed
that ectopic Meox2 suppressed epithelial cell proliferation
in cooperation with Tgfβ1, and mediated induction of the
cell cycle inhibitor gene p21 [54]. Furthermore, they
showed that Meox2 failed to promote EMT and partially
blocked Tgfβ1-induced EMT [54]. Considering the re-
quirement of EMT during palatal fusion, Meox2 expres-
sion needs to be downregulated at the later stages of
palatogenesis, as observed in both WT and TGFβ3+/−
mice in our study.
Sonic hedgehog, Shh, is a member of the hedgehog fam-
ily of secreted proteins and has been implicated as the key
inductive morphogen in patterning of vertebrates during
organogenesis; particularly the ventral neural tube, the
anterior-posterior limb axis, and the ventral somites [55].
Shh signaling plays essential roles in craniofacial develop-
ment by regulating a number of transcription factors and
signaling interactions that take place between the epithe-
lium and mesenchyme during normal palatogenesis [56].Lan et al. (2009) showed that Shh is predominantly
expressed in palatal epithelia and signals directly to the
palatal mesenchyme to regulate palatal mesenchyme cell
proliferation through maintenance of cyclin D1 and D2
(Ccnd1 and Ccnd2) expression [56]. Recently, Sasaki et al.
(2007) showed that Shh expression in the palates of
Tgfβ3-null mice was reduced throughout E12.5–E15.5,
and thereby proposed that Shh may be involved in TGFβ3
regulation of normal palatal fusion [57]. Our results fur-
ther support that upregulated expression of Shh is neces-
sary for the successful completion of palatogenesis, as
observed in the TGFβ3+/− and WT mice, but not in
TGFβ3−/−.
SIX homeobox 3 (Six3) is a transcription factor crucial
to embryonic development by providing the necessary
instructions for the formation of the forebrain and eye
development [58]. Similar to Shh [59], mutations in the
homeodomain of the human Six3 gene cause holopro-
sencephaly and are associated with midline facial cleft -
tessier cleft 14 [60]. In mice, it has been shown that Six3
protein increases expression of Ccnd1 protein [61], which
is directly related to TGFβ signaling (Figure 6). Our results
indicate that Six3 expression has to be upregulated after
E14.5 for the precise progression of palate development.
Therefore, the interaction of Six3 with TGFβ3 and their
mechanism of activation deserve further analysis using
biological techniques.
Cellular biofunctions and TGFβ pathway molecules
The expression pattern-clustered CP genes interconnect
each other to facilitate cellular biofunctions and canon-
ical pathways. The relevance of these groups of gene
datasets was detected using IPA core analysis (Figure 5).
Our primary objective in this study was to analyze the
transcriptomal differences among the alleles of TGFβ3
knockout mice. Thus, it was critical to find the relationship
of CP genes with the TGFβ signaling pathway, which
encompasses 89 molecules (Figure 7). TGFβ3 controls the
fusion of palatal shelves by EMT and apoptosis [5,14,62].
Furthermore, TGFβ1 and TGFβ2 regulate mesenchymal cell
proliferation and extracellular matrix synthesis in the palate
[63]. Although not all of the molecules of the TGFβ signal-
ing pathway are associated with CP genes, it is noteworthy
that all of the related CP genes followed the Smad-
dependent pathway. This may indicate that TGFβ3 regulates
the CP genes through Smad-signaling, with ancillary in-
volvement of ERK, PI3K, JNK, MAPK, etc. Thus, the pro-
moter regions of these CP genes should be analyzed for
Smad-binding elements using ChIP-PCR or ChIP-Seq. The
majority of these CP genes followed the p8 expression pat-
tern in WT mice, which represents the unchanged-
downregulated expression pattern. This suggests that TGFβ
molecules are required during E14.5 and E15.5, but are less
necessary during E16.5, which correlates with our previous
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throughout the degradation of the palatal seam [5].
Overall, these sequencing and bioinformatics analysis
studies are used as gene identification tools for future
experiments to further understand the detailed mechan-
ism of palate development. The 8 putative CP causing
genes and Smad-dependent TGFβ signaling molecules will
be analyzed in detail using gene and protein expression
studies, as well transcription factor and promoter binding
assays.Conclusions
As a result of the complexity of TGFβ signaling, appar-
ently simple but highly important questions regarding
the development of cleft palate remain unanswered, in-
cluding: what is the genetic footprint of TGFβ3 in nor-
mal palatogenesis and how does the deregulation of
TGFβ3 signaling cause cleft palate? In this study, we
have attempted to answer these questions through the
extensive quantitative transcriptome analysis of the
palates of TGFβ3 knockout mice through RNA sequen-
cing technology. Our study represents the first detailed
analysis of palatal transcriptomes generated by RNA-Seq
technology during critical stages of palatogenesis. The
dataset described here will provide an enriched resource
for searching transcripts that may play key regulatory
roles at different stages of palatal development. Further-
more, we identified 8 key genes which may play funda-
mental roles in the development of cleft palate in
TGFβ3−/− mice. Our combined results provide an initial
understanding of the complex genetic mechanism of
TGFβ3-mediated palatogenesis, and may lead to the
identification of genes for the targeted prenatal treat-
ment of cleft palate.Methods
Mouse breeding and genotyping
The generation and genotyping of TGFβ3−/− mice have
been described previously [25]. TGFβ3 heterozygous (+/−)
C57BL/6J male and female mice were provided by Tom
Doetschman (BIO5 Institute, University of Arizona, AZ).
Mice were housed in accredited animal facilities at the Uni-
versity of Nebraska Medical Center (UNMC). All
procedures were approved by the IACUC (Institutional Ani-
mal Care and Use Committee) of UNMC. Homozygous
(−/−) embryos were obtained by mating TGFβ3+/− male and
female mice. The morning that the vaginal plug was pulled
was considered embryonic day (E) 0.5. Tissue samples were
individually labeled and embryonic tails were used for geno-
typing by PCR. Genomic DNA was prepared using the Wiz-
ard Genomic DNA Purification Kit (Promega – A1120).
The primers used for TGFβ3 were as follows:TGFβ3 Forward 50 TGGGAGTCATGGCTGTAACT 30
TGFβ3 Reverse 50 CACTCACACTGGCAAGTAGT 30
pMC1-Neo 50 GCCGAGAAAGTATCCATCAT 30
These primers amplified 600 bp and 400 bp fragments
for the mutated and WT alleles, respectively. PCR
conditions were 30 cycles of 95°C for 30 seconds, 57°C
for 45 seconds, 72°C for 1 minute, followed by one cycle
of 72°C for 10 minutes.
Typically, 8 fetuses were obtained from each preg-
nancy in a Mendelian-fashion 3 allelic-genotype (1:2:1)
as 2 TGFβ3−/−, 4 TGFβ3+/−, and 2 WT. Palates were
extracted from fetuses as described earlier [2] at 3 time
points (E14.5, E15.5, and E16.5) as duplicates and the
tissues were stored in RNAlater RNA Stabilization
Reagent (QIAGEN, CA) to preserve transcript integrity.
In order to evaluate the reproducibility of our experi-
mental samples and procedures, two independent bio-
logical and technical replicates were assayed for each
gestational age and each allele resulting in 36 (n = 3 ×
3 × 2 × 2) samples for sequencing.
Protein, RNA extraction, construction of small RNA
libraries, and RNA-Seq
Total proteins were extracted from the palatal shelves
collected from embryonic (E) 15.5 and western blot was
performed as previously done in our lab and described
in [9,10] using antibody against TGFβ3 (R & D Systems,
MN). We extracted the RNA using the RNeasy Kit
(QIAGEN, CA) and evaluated the RNA for purity and
concentration by ultraviolet spectroscopy (NanoDrop,
Wilmington, DE). RNA integrity numbers (RIN) [64,65],
based on an algorithm for judging the integrity of RNA
samples, were evaluated using the Agilent 2100
Bioanalyzer (Agilent Technologies, Palo Alto, CA). Li-
braries were prepared using the Illumina mRNA-Seq
Sample Preparation Kit (San Diego, CA) according to
the manufacturer’s instructions. Briefly, poly(A) + RNA
was recovered from 1 μg of total RNA using two rounds
of isolation with oligo-dT-coated Sera-Mag magnetic
beads. The recovered poly (A) + RNA was then chem-
ically fragmented. RNA fragments were converted to
cDNA using SuperScript II and random primers. The
second strands were synthesized using RNaseH and
DNA Pol I. The ends of the cDNA were repaired using
T4 DNA polymerase, T4 polynucleotide kinase, and
Klenow DNA polymerase. A single adenosine was added
to the 30 end using Klenow fragment (30 to 50 exo
minus). Adaptors were attached to both ends of the
cDNA using T4 DNA ligase. RNA fragments were
extracted from a 2% low range ultra agarose sizing gel.
The fragments were amplified by 15 cycles of PCR using
Phusion DNA polymerase. Libraries were validated with
Agilent Bioanalyzer (Palo Alto, CA). Libraries were
Ozturk et al. BMC Genomics 2013, 14:113 Page 15 of 18
http://www.biomedcentral.com/1471-2164/14/113diluted to 10 pM and applied to an Illumina flow cell
using the Illumina Cluster Station. Sequencing was
performed on Illumina HiSeq 2000 according to the
manufacturer’s instructions [66,67].Mapping and quantification of transcripts
RNA-Seq datasets were analyzed by following the re-
cently published RNA-Seq protocol [31]. The 36 samples
(paired-end reads, including biological replicates and
technical replicates; n = 3 × 3 × 2 × 2) were individually
mapped onto the mouse genome (mm9, build name
NCBIM37) by using TopHat v1.4.1 [68-70]. Preprocessing
steps were not applied to the raw data (fastq) files because
the sequencing quality was very high in both 30 and 50
ends according to the FastQC reports [71]. The relative
abundance of reads was normalized to the total read num-
ber and shown as fragments per kilobase per million
mapped (FPKM) [71]. After the alignment, Cufflinks v1.3.0
[72-74] was used to estimate the abundances of transcripts.
Cuffdiff from Cufflinks repository was used to perform
pairwise comparisons between different genotypes and ges-
tational groups. The dispersion between each biological
replicate was also tested by Cuffdiff, as well as the disper-
sion between each technical replicate. CummeRbund
(http://compbio.mit.edu/cummeRbund/) software [31]
provides functions for creating commonly used expression
plots, such as: volcano, scatter and box plots, using
processed data from Cuffdiff. We used CummeRbund to
generate scatter plots to use for quality assessments of
both biological and technical replicates.
We used the VennDiagram [75], an R package that
enables the automated generation of highly-
customizable, high-resolution Venn diagrams, to illus-
trate the number of transcripts in each experimental
group which passed the significance and fold change
(FC ≥ 2.0) filtrations through Cufflinks. Pattern-
oriented listings of CP genes were illustrated with
GeneVenn, a web application for comparing gene lists
(Additional file 5).Identification of cleft palate genes
We used the OMIM (Online Mendelian Inheritance in
Man) database to retrieve 280 genes and loci involved in
genetic diseases associated with CP syndromes in
humans. We used information from developmental biol-
ogy studies demonstrating CP in knockout mouse
models and the Mouse Genome Informatics (MGI) web-
site with the mammalian phenotype browser, the inter-
national database resource for the laboratory mice, to
retrieve 128 genes (out of 223 genotypes) causing CP in
mice. The pattern-oriented heatmaps of CP genes were
illustrated by using R pheatmap packageBiological interpretation and pathway analysis
The effects of TGFβ alleles on CP genes during palato-
genesis were examined in the context of differentially
expressed human and mouse genes using Ingenuity Path-
way Analysis (IPA), (Ingenuity Systems, CA), a web-
delivered application used to discover, visualize, and explore
relevant networks. After performing statistical analysis and
filtering of the RNA-Seq data, the Entrez IDs and FPKM
values of each group were uploaded to IPA as a dataset.
Each identifier was mapped to its corresponding gene ob-
ject in the IKB. Interactions were then queried between
these datasets and all other gene objects stored within IPA
to generate a set of direct interaction networks that were
overlapped. The significant genes were categorized,
compared to functional categories in the IPA database, and
ranked according to their p-values. P-values less than 0.05
indicate a statistically significant, nonrandom association
between a set of significant genes and a set of all genes
related to a given function in the IKB [76]. Through the as-
sessment of differentially expressed genes, cellular processes
that were most significantly altered in our dataset were:
gene expression, cellular development, cellular growth and
proliferation, cell signaling, cell morphology, cell death and
survival, cellular movement, and cell cycle. Based on these
IPA analyses, the cellular biofunction categories mentioned
above and the TGFβ pathway were filtered among other
cellular processes and canonical pathways; then ranked
according to their p-values and represented as a color
coded matrix. Datasets associated with the TGFβ pathway
were overlaid using the IPA Pathway Designer.Additional files
Additional file 1: TGFβ3 protein expression in the alleles of TGFβ3
knockout mice. Western blot analysis show that while homozygous
(HM; −/−) palates did not show any expression TGFβ3 protein in the
palate collected at E15.5 heterozygous (HT; +/−) palates expressed
limited levels of the TGFβ3 protein while the wild-type (WT; +/+) palates
expressed higher level of TGFβ3 protein.
Additional file 2: Table listing RNA integrity numbers (RIN) to
monitor quality and degradation of RNA samples.
Additional file 3: Table showing the number of reads per replicate
of RNA samples.
Additional file 4: Validation of biological and technical replicates
using CummeRbund. The read numbers per transcript between the
biological replicates were compared. Since the read number per
transcript (FPKM value) ranged from 0 to >10,000, the read number + 1
was transformed by log10. Each dot represents data from one transcript.
There was a high correlation between the two sequencing results
(r = 0.98, Pearson’s correlation; p < 0.001 two tail).
Additional file 5: Venn diagrams of all significantly differentially
expressed genes. Differential expression of transcripts within TGFβ3
alleles (TGFΒ3−/−, TGFΒ3+/−, and WT) were compared using Venn
diagrams. Lists of differentially expressed genes with their EntrezIDs were
uploaded to the R VennDiagram package [75], the query was run, and
the detected numbers and gene lists were exported to MS Excel.
Relationships among the lists of differentially expressed genes within
TGFβ3 allelic mice are depicted as intersections or uniqueness and
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E16.5). A significant overlap of differentially expressed genes was
observed among the allelic variants at each gestational age. Venn
diagrams were not drawn per scale.
Additional file 6: Table listing the names of the genes significantly
increased from E14.5 to E15.5 followed by downregulation in E16.5
and their.
Additional file 7: Venn diagram of cleft palate (CP) related genes
acquired from OMIM and MGI Using the OMIM (Online Mendelian
Inheritance in Man) database, we identified 280 genes and loci
involved in genetic diseases associated with CP syndromes in
humans. Several studies have developed knockout mouse models which
exhibit CP [77]. We used the Mouse Genome Informatics (MGI)
international database resource for laboratory mice to identify 128 genes
(out of 223 genotypes) that cause CP in mice. The mouse genes were
filtered based on gene names only, because some of the same genes
were either studied by different labs or have splice variants, and as a
result they were listed several times as genotypes in the MGI database.
The human and mouse CP-associated genes were compared to find
common genes, and the Homologene tool of NCBI [78] was used to
compare and detect the orthologs of human and mouse CP related
genes. We determined that 50 (out of 280) human CP related genes and
loci were not represented, i.e. non-orthologs, within the mouse genome.
Additional file 8: Ideogram of CP genes on chromosomes. A
zoomable Circos image is drawn based on circular composition of CP
genes on chromosomes. Data tracks appear inside and/or outside the
circular layout. When the PDF file is magnified, tracks include FPKM
values of CP genes as histograms and labeled from the outer circle to
inner circle as “gene name, 14.5HM, 15.5HM, 15.5HM, 14.5HT, 15.5HT,
16.5HT, 14.5WT, 15.5WT, and 16.5WT”.
Additional file 9: Table listing the all the CP genes sorted
according to their pattern.
Additional file 10: Table showing differentially expressed
molecules clustered into GO of cellular biofunctions.
Additional file 11: Stages of palatogenesis in the mouse.
(A) Time-course of palate development in mice. (B-F) Scanning electron
micrographs showing oral views of the secondary palate at representative
developmental stages [reprinted from Kaufman (Kaufman, 1992) with
permission]. Orange lines mark sites of fusion between the medial nasal
processes and maxillary processes, white arrowheads point to initial
outgrowths of the primary palate, white arrows point to the initial outgrowth
of the secondary palatal shelves, red arrowheads mark the initial site of palatal
adhesion and fusion, and the yellow arrowhead points to the gap between
the primary and secondary palates that will disappear following fusion
between these tissues. (G-U) Representative histological frontal sections from
anterior (G-K), middle (L-P), and posterior (Q-U) regions of the developing
palate at each indicated stage. The middle palate region is flanked by the
developing upper molar tooth germs (black arrows in M-P) and corresponds
to the palatine region of the future hard palate. The posterior palate region
corresponds to the future soft palate. At E11.5 (G,L,Q), the palatal shelf
outgrowths arise from the oral surface of the maxillary processes. At E13.5 (H,
M,R), the palatal shelves exhibit distinct shapes along the AP axis. By E14.5 (I,N,
S), the palatal shelves have elevated to the horizontal position. At ~ E15.0 (J,O,
T), the palatal shelves make contact at the midline and initiate fusion by
formation of the midline epithelial seam (MES) in the mid-anterior region
(arrowhead in O). By E15.5 (K,P,U), palatal shelf fusion is evident in the middle
and posterior regions, with complete removal of the MES (black arrowheads
in P,U). Remnants of the MES can still be seen in the anterior region (K) at this
stage and the palatal shelves also fuse superiorly with the nasal septum.
Magnification is not equivalent between stages. MdbP, mandibular process;
MNP, medial nasal process; MxP, maxillary process; NS, nasal septum; PP,
primary palate; PS, palatal shelf; SP, secondary palate; T, tongue. Adapted from
Bush J O and Jiang R. Development 139, 231–243 (2012).Abbreviations
TGFβ3: Transforming growth factor β 3; NGS: Next generation sequencing;
RNA-Seq: RNA Sequencing; FC: Fold change; IPA: Ingenuity pathway analysis;
E: Embryonic day; CP: Cleft palate; TGFΒ3−/−: Homozygous; WT: Wild-type;TGFΒ3+/−: Heterozygous; FPKM: Fragments per kilo base per million
mapped.
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